SREN has been the subject of a number of other research reports. Morgan Stanley set a CHF 76.50 target price on shares of Swiss Re AG and gave the stock a sell rating in a research note on Saturday, May 20th. Nord/LB set a CHF 94 target price on shares of Swiss Re AG and gave the stock a neutral rating in a research note on Saturday, May 20th. Finally, Sanford C. Bernstein set a CHF 89 target price on shares of Swiss Re AG and gave the stock a neutral rating in a research note on Monday, May 22nd. One research analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the stock. The company presently has an average rating of Hold and a consensus target price of CHF 95.79.
Shares of Swiss Re AG (SREN) traded up 0.91% during mid-day trading on Wednesday, reaching CHK 88.25. The company’s stock had a trading volume of 3,872,343 shares. The stock has a 50 day moving average of CHK 88.23 and a 200-day moving average of CHK 91.53. Swiss Re AG has a one year low of CHK 79.00 and a one year high of CHK 98.50.
Swiss Re AG Company Profile
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Receive News & Ratings for Swiss Re AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re AG and related companies with MarketBeat.com's FREE daily email newsletter.